Published in TB and Outbreaks Week, October 14th, 2003
The collaborative phase I study looks at a prime-boost regimen that in an earlier preclinical investigation in monkeys found a higher level of immune response against HIV-1 than either vaccine used separately. Phase I represents the earliest stage of human testing for a potential vaccine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.